Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
5083623
Reference Type
Journal Article
Title
Perfluorononanoic acid (PFNA) alters lipid accumulation in bovine blastocysts after oocyte exposure during in vitro maturation
Author(s)
Hallberg, I; Kjellgren, J; Persson, S; Örn, S; Sjunnesson, Y
Year
2019
Is Peer Reviewed?
1
Journal
Reproductive Toxicology
ISSN:
0890-6238
EISSN:
1873-1708
Volume
84
Page Numbers
1-8
Language
English
PMID
30502403
DOI
10.1016/j.reprotox.2018.11.005
Web of Science Id
WOS:000462417700001
URL
https://search.proquest.com/docview/2149016535?accountid=171501
Exit
Abstract
Perfluorononanoic acid (PFNA) is one of the perfluoroalkyl acids present in human tissues. In this study, effects on early embryo development after PFNA exposure were investigated using the bovine in vitro production system. Oocytes were exposed to PFNA during maturation in vitro (10 μg mL-1 and 0.1 μg mL-1), and then fertilized and cultured in parallel with control groups. Developmental parameters (cleavage, blastocyst formation) were followed and embryo quality evaluated (stage, grade). Embryos developed after exposure to 0.1 μg mL-1 were stained to distinguish nuclei, active mitochondria and neutral lipids. 10 μg mL-1 of PFNA had a severe negative effect on blastocyst formation (OR: 0.27 p < 0.05), an effect not observed at 0.1 μg mL-1. However, lipid droplet distribution was significantly altered in embryos exposed to 0.1 μg mL-1, suggesting a disturbance of lipid metabolism after exposure to sublethal levels of PFNA during oocyte maturation in vitro.
Keywords
Fluorocarbons; perfluorononanoic acid; 5830Z6S63M; Index Medicus; Image analysis; Developmental toxicology; Lipid droplet; Endocrine disruption; Animals; Fertilization in Vitro; Embryonic Development -- drug effects; Oocytes -- drug effects; Oocytes -- physiology; In Vitro Oocyte Maturation Techniques; Embryo, Mammalian -- physiology; Blastocyst -- physiology; Embryo, Mammalian -- drug effects; Fluorocarbons -- toxicity; Blastocyst -- drug effects; Lipid Metabolism -- drug effects
Tags
PFAS
•
Additional PFAS (formerly XAgency)
Literature Search November 2019
Other Sources
TEDX
Screened Studies
Excluded
Exclude (TIAB)
•
Expanded PFAS SEM (formerly PFAS 430)
Litsearch: September 2019
Web of Science
Other Sources
PFAS TOX Database
Screened Studies
Excluded
Exclude (TIAB)
Not prioritized for screening
Perfluorooctane
•
PFAS 150
Literature Search Update December 2020
WOS
Literature Search August 2019
PubMed
Web of Science
Other sources
PFAS TOX Database
Not prioritized for screening
Perfluorononanoic acid
Perfluorooctane
•
PFHxS
•
PFNA
Literature Search
Pubmed
WOS
PFNA May 2019 Update
Pubmed
Web of Science
LitSearch: May 2019 - May 2020
WoS
Title and Abstract Screening
Tagged as Supplemental
In silico or modeling
In vitro
June 2022 Pelch Database
•
PFOA (335-67-1) and PFOS (1763-23-1)
Literature Search Update (2013-2019)
WOS
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity